EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diammonium Glycyrrhizinate Exerts Broad-Spectrum Antiviral Activity Against Human Coronaviruses by Interrupting Spike-Mediated Cellular Entry

Shuo Wu, Ge Yang, Kun Wang, Haiyan Yan, Huiqiang Wang, Xingqiong Li, Lijun Qiao, Mengyuan Wu, Ya Wang, Jian-Dong Jiang, Yuhuan Li

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shuo Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Develo…. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Antiviral Agents, Virus Internalization, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Initiative for Innovative Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhizic acid (GA) and its derivatives have been reported to have potent pharmacological effects against viral infections, including SARS-CoV and SARS-CoV-2. However, their antiviral mechanisms against coronaviruses are not fully understood. In this study, we found that diammonium glycyrrhizinate (DG) can effectively reduce infections of several human coronaviruses, including HCoV-OC43, HCoV-229E, and SARS-CoV-2, as well as newly emerged variants, with EC50 values ranging from 115 to 391 μg/mL being recorded. Time-of-addition and pseudotype virus infection studies indicated that DG treatment dramatically inhibits the process of virus entry into cells. Furthermore, we demonstrated that DG broadly binds to the RBD of human coronaviruses, thereby blocking spike-mediated cellular entry, by using TR-FRET-based receptor-binding domain (RBD)-ACE2 interaction assay, capillary electrophoresis (CE), and surface plasmon resonance (SPR) assay. In support of this notion, studies of molecular docking and amino acid mutation showed that DG may directly bind to a conserved hydrophobic pocket of the RBD of coronaviruses. Importantly, intranasal administration of DG had a significant protective effect against viral infection in a HCoV-OC43 mouse model. Finally, we found that combinations of DG and other coronavirus inhibitors exhibited antiviral synergy. In summary, our studies strongly reveal that DG exerts broad-spectrum antiviral activity against human coronaviruses by interrupting spike-mediated cellular entry, demonstrating the pharmacological feasibility of using DG as a candidate for alternative treatment and prevention of coronavirus infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidAntiviral AgentsVirus InternalizationSpike Glycoprotein, CoronavirusSARS-CoV-2HumansAnimalsMiceMolecular Docking SimulationCoronavirus OC43, HumanCOVID-19 Drug TreatmentCoronavirus 229E, HumanCOVID-19Angiotensin-Converting Enzyme 2HEK293 Cells

Stichwörter der Autor:innen

RBD-binding activitybroad spectrumcoronavirusdiammonium glycyrrhizinatespike-mediated cellular entry

Substanzen

Glycyrrhizic AcidAntiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, NHC Key Laboratory of Biotechnology for Microbial Drugs, Instit…
  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Förderung

  • CAMS Initiative for Innovative Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Wu, S., Yang, G., Wang, K., Yan, H., Wang, H., Li, X., Qiao, L., Wu, M., Wang, Y., Jiang, J. D., & Li, Y. (2025). Diammonium Glycyrrhizinate Exerts Broad-Spectrum Antiviral Activity Against Human Coronaviruses by Interrupting Spike-Mediated Cellular Entry. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136334

Vancouver

Wu S, Yang G, Wang K, Yan H, Wang H, Li X, et al. Diammonium Glycyrrhizinate Exerts Broad-Spectrum Antiviral Activity Against Human Coronaviruses by Interrupting Spike-Mediated Cellular Entry. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136334

BibTeX
@article{Wu2025,
  author = {Wu, Shuo and Yang, Ge and Wang, Kun and Yan, Haiyan and Wang, Huiqiang and Li, Xingqiong and Qiao, Lijun and Wu, Mengyuan and Wang, Ya and Jiang, Jian-Dong and Li, Yuhuan},
  title = {Diammonium Glycyrrhizinate Exerts Broad-Spectrum Antiviral Activity Against Human Coronaviruses by Interrupting Spike-Mediated Cellular Entry},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136334}
}
Kostenlos starten →